Page 7 - Exact Sciences News Today

Perfromance Wealth Partners LLC reduced its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 10.7% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 4,737 shares of the medical research company’s stock after selling 565 shares during the period. […]

Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) was the target of a significant drop in short interest in March. As of March 15th, there was short interest totalling 6,520,000 shares, a drop of 7.4% from the February 29th total of 7,040,000 shares. Based on an average trading volume of 1,940,000 shares, the short-interest ratio […]

Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) saw a large drop in short interest in the month of March. As of March 15th, there was short interest totalling 6,520,000 shares, a drop of 7.4% from the February 29th total of 7,040,000 shares. Based on an average trading volume of 1,940,000 shares, the short-interest ratio […]

Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) was the target of a significant drop in short interest in March. As of March 15th, there was short interest totalling 6,520,000 shares, a drop of 7.4% from the February 29th total of 7,040,000 shares. Based on an average trading volume of 1,940,000 shares, the short-interest ratio […]

Values First Advisors Inc. increased its stake in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 21.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 12,973 shares of the medical research company’s stock after purchasing an additional 2,329 shares during the […]

/PRNewswire/ -- Workflow Services, an automated platform that solves point-of-care clinical service delivery for pharmacies, announced a new agreement with...

The recent rise in colorectal cancer incidence and mortality in younger patients has sparked a serious discussion about strategies to increase screening uptake and adherence, raising questions about the role of noninvasive tests versus the traditional “gold standard,” colonoscopy.

Results indicate potential of a minimally invasive screening tool to detect most common form of Esophageal Cancer, a highly treatable cancer if caught early ...

Company also receives national and regional Top Workplace honors from USA Today and Wisconsin State Journal ...